Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 3Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 90Prostatic Neoplasms 55Lymphoma 34Leukemia 32Carcinoma, Non-Small-Cell Lung 31Multiple Myeloma 30Head and Neck Neoplasms 30Colorectal Neoplasms 29Squamous Cell Carcinoma of Head and Neck 28Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Colonic Neoplasms 24Leukemia, Myeloid, Acute 22Rectal Neoplasms 21Neoplasm Metastasis 20Sarcoma 19Ovarian Neoplasms 19Central Nervous System Neoplasms 18Uterine Cervical Neoplasms 17Hodgkin Disease 17Burkitt Lymphoma 15Brain Neoplasms 15Carcinoma, Ovarian Epithelial 14Pain 12Lymphoma, Follicular 12Urinary Bladder Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Fallopian Tube Neoplasms 11Endometrial Neoplasms 11Astrocytoma 11

Interventions

Watchful Waiting 1Vincristine 1Radiotherapy, Conformal 1Platinum 1Observation 1Mesna 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cyclophosphamide 1Cisplatin 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × NETWORK × Ependymoma × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡